Cancer Doctor
Cancer Doctor

Biomakers Cancer Test

In this video, Aristo Vojdani spends about 30 minutes speaking on "Biomakers Cancer Test" at the 32nd Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.

About Aristo Vojdani

ARISTO VOJDANI, Ph.D. in Immunology and Microbiology from Bar Ilan University, Israel. He completed his post-graduate work at both Tel Aviv University Medical Center and the University of California, Los Angeles.

Currently, Dr. Vojdani is an Associate Professor at Charles Drew School of Medicine and Science in Los Angeles and Vice-President of Research and Development for Immunosciences Lab, Inc. in Beverly Hills, both in California.

Immunosciences Lab, a licensed Clinical Laboratory, offers a collection of tests and panels scientifically designed to detect immunological injuries due to environmental factors such as chemicals and viruses. These services include: Comprehensive Immune System Evaluation, Lymphocyte Immune Function Testing, Immunotoxicology, Immunology of Silicone and Gastrointestinal Evaluation. Recently, testing targeted at cancer, Alzheimer’s atherosclerosis, diabetes and aging have been developed.

Dr. Vojdani’s areas of specialty include immune function disorders, chemically-induced autoimmune diseases, cell destruction mechanisms and immunoassay technology development. He recently had the privilege of testifying before the US Senate Committee on Veterans Affairs to provide crucial evidence on the effect of chemical agents on veterans who fought in the Persian Gulf War. His testimony helped secure the passage of legislation enabling veterans to receive free medical care for Neuroimmunological Disorders acquired during service in the Persian Gulf.

Dr. Vojdani has published extensively in such peer-reviewed Journals as Internal Medicine, Journal of Nutritional Environmental Medicine and Cancer Research.

He may be contacted by phone 800-950-4686, website and e-mail [email protected].


It is a great honor and pleasure to be here. I guess I'm a leftist. I'm going to look this way. My friend Dr. Howser was right. It was looking to the right during these past two, three days. We heard a lot of information, excellent information from very dynamic speakers. And really the message was about the importance of the immune system as well as early detection and prevention. So that's really, you know, some kind of a summary of my talk. In the laboratory settings, we are interested in developing biomarkers, biomarkers meaning laboratory tests, which can signal and really that the signal is the heart of the matter in here, that, you know, a signal of a disease not to wait until you have, for example, tumor markers are elevated.

We are very interested that early stage of a disease. So those markers are developed based on the following facts that infectious agents or toxic environmental chemicals, after entering into our system, affect our first line of defense or the immune system. Further can damage our DNA and all of that damage results in a disease, in this case. Cancer. However, along with that, we have many other. Markers in place which are protecting us against these. Damage is done by environmental factors, including infectious agents and toxic environmental chemicals. And one of them is Cytochrome P. 450 enzymes by the liver.

So they can metabolize, metabolize the chemicals and get rid of the chemicals from the system, therefore, can prevent cancer. DNA repair enzymes which repair the damage, DNA also can prevent cancer.

The immune function, natural killer cytotoxic activity, which we heard before. How important are the function of those natural killer cells in destroying tumor cells and preventing cancer? And finding the levels of antioxidants in the blood can protect us against cancer. So we call these markers of damage. And these are markers of protection together. Are bio markers of a disease.

Now, cancer, which you see today, probably started somewhere in your body 20 years ago.

And therefore, we have to look at biomarkers that if this is a volcano and, you know, when the volcano erupts, that's really full blown cancer. But down by them in here, 10, 15, 20 years earlier, the disease started from oxidative stress. Damage to DNA, gene mutation, change in the cell cycle, cell mitosis, and then activation of proto oncogenes. And finally, the effects of the immune function and so forth. Low natural killer selectivity. If all that are in place 10, 15, 20 years later, will we end with full blown cancer? So therefore, it's very important to know what is causing cancer. We

Genomic Studies

Popular Videos